01440 782 100(Monday - Friday 8.30am - 5pm)

The EpiCentre is officially open!

People gathered for EpiCentre opening

Today, (Monday, 2nd November 2020), The EpiCentre in Haverhill, was opened at a ribbon cutting ceremony attended by local dignitaries.

Present at the opening of the innovation centre was Austen Adams the business board chairman of Cambridgeshire and Peterborough Combined Authority, Councillor John Griffiths, leader of West Suffolk Council and Nic Rumsey, managing director of developer Jaynic.

Already four companies have signed up to take space in the building and discussions are in hand with other potential occupiers.

Development of The EpiCentre was made possible with a £6.2m cash boost provided jointly through a £3.5m loan by West Suffolk Council and £2.7m of Local Growth Fund investment from the Cambridgeshire and Peterborough Combined Authority, to bring jobs and employment to Haverhill Research Park and its enterprise zone.

Business board chairman Austen Adams said: “The EpiCentre is a brilliant example of an innovative project that will help to unlock the East of England’s growth potential by helping start-ups to thrive and create new jobs.

“High potential and innovative companies across the East have the power to be the catalyst for building back better and I think this is a great example of an investment that will pay dividends by helping drive inclusive local economic growth.

“I am really excited to learn more about the companies who will be occupying the Epicentre.”

Councillor John Griffiths said: “It is great to see the EpiCentre, which is about creating job opportunities, increasing skills and new opportunities especially for young people in and around Haverhill, finished and ready to use. Four businesses have already signed up which shows business confidence in what we are all trying to achieve, and we hope more will soon follow. I would like to thank all those involved for making this ambitious ambition a reality for Haverhill, West Suffolk and the region.”

Jaynic managing director Nic Rumsey, said : “I would like to thank the combined authority and West Suffolk Council for their unwavering moral and financial support that has made this development possible and look forward to seeing this becoming a thriving centre for the benefit of the wider community.”

Tim Smith, deputy managing director of Oxford Innovation, the operator of The EpiCentre, said: “We are off to a flying start with four companies already signed up and more in the pipeline for this superb  facility, which will become a prime business hub for entrepreneurs and fast growing companies in the surrounding area.”

The new 30,000 sq ft four-storey EpiCentre is located adjacent to the Spirit of Enterprise roundabout creating a prominent ‘landmark’ building at the entrance into Haverhill.

The EpiCentre has over 60 office suites available from 17sqm (172 sqft) up to 78sqm (840sqft) including three flexible shared purpose-built laboratory spaces with access to specialist equipment, together with conference and meetings rooms, training facilities and a ‘work-hub’ area for shared working.

These suites are available for pre-let immediately, and are supplemented by communal breakout spaces, a café, and meeting and conference rooms.

Oxford Innovation is the UK’s leading operator of innovation centres with 26 managed facilities around the British Isles.  An integral part of its offer is innovation services to entrepreneurs, including business planning advice, coaching and mentoring. It also manages investment networks that link investors with entrepreneurs seeking funding from £20,000 to £2m.

Amphista Therapeutics – Graduated in March 2022

Since graduating from The EpiCentre in March 2022, Amphista has established itself at Granta Park, Cambridge, a world-leading hub for biopharmaceutical innovation. Amphista’s mission is to unlock the full potential of Targeted Protein Degradation (TPD) by developing a new generation of transformational medicines using their proprietary Targeted Glue® technology.

READ MORE »

MultiplAI Heath – Graduated in July 2023

MultiplAI Health is redefining the future of healthcare with their ground-breaking RNA-based, AI-driven screening technology. After graduating from The EpiCentre in July 2023, MultiplAI Health has continued to accelerate innovation in early disease detection, developing a simple blood test that transforms how cardiovascular and complex diseases are diagnosed.

READ MORE »

K9 Digital – Graduated in July 2025

K9 Digital stands out as a creative powerhouse within The EpiCentre’s vibrant community. Founded by industry veterans with a passion for character creation, K9 Digital specialises in 3D character, creature, and animal art for games, VR, TV, and film.

READ MORE »

PES Technologies – Graduated in May 2025

PES Technologies embodies the pioneering spirit at the heart of The EpiCentre community. After graduating from the centre in May 2025, PES Technologies has continued to make waves in the agri-tech sector, driven by their mission to revolutionise soil health measurement.

READ MORE »

Ready to find your new workspace?

Be at centre of an inspiring and ambitious science and technology community. Be at The EpiCentre.

Book a Tour

Join an inspiring community of innovators and entrepreneurs.

  • Book a tour of The EpiCentre
  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office, lab, coworking or meeting space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
Name

Subscribe for Updates

Stay in touch with what’s happening at The EpiCentre. Pop in your details below and confirm you’re happy for us to send you emails, and we’ll keep you up to date with all that’s happening at The EpiCentre.

Name

Disclaimer: The EpiCentre uses the information you provide on this form to get in touch with you and provide updates and for marketing purposes. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. We treat all personal information with respect. By subscribing, you agree that we may process your information in accordance with these terms.

Get in Touch

Join an inspiring and ambitious community. 

  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office, lab, coworking or meeting space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
I'm interested in...
Name(Required)

Download our lab space brochure to find out more about our range of workspace packages and facilities

This field is for validation purposes and should be left unchanged.

Download our lab space brochure to find out more about our range of workspace packages and facilities

This field is for validation purposes and should be left unchanged.

Ready to explore our Lab Space options?

Space to experiment, space to research

  • Get more information on pricing & availability
  • Book a tour of The EpiCentre lab space
  • Have your questions answered
  • Reserve your lab space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
Name

Ready to sign up for Lab space?

Space to experiment, space to research

  • Get more information on pricing & availability
  • Arrange a viewing of The EpiCentre lab space
  • Have your questions answered
  • Reserve your lab space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

This field is for validation purposes and should be left unchanged.
Name

Covid-19 Statement

Update – 11 August 2022

Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.